Arkolith/Insider Trading/XERS/Form 4

Johnson Kenneth Erland

See RemarksXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Feb 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2025Tax withholding(F)26K$3.56$92K320K
Jan 31, 2025Tax withholding(F)15K$3.56$55K346K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001867096-25-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML